Similar articles

• Challenges in design of biochemical assays for the identification of small molecules to target multiple conformations of protein kinases.

  Chène P. Chène P. Drug Discov Today. 2008 Jun;13(11-12):522-9. doi: 10.1016/j.drudis.2008.03.023. Epub 2008 May 5. Drug Discov Today. 2008. PMID: 18549979 Review.
• CHI's Fourth Annual Drug Discovery Chemistry Conference. Kinase inhibitor chemistry: charting the chemical space. 7-8 April 2009, San Diego, CA, USA.

  Seneci P. Seneci P. IDrugs. 2009 Jun;12(6):358-62. IDrugs. 2009. PMID: 19517315 No abstract available.
• A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding.

  Bogoyevitch MA, Fairlie DP. Bogoyevitch MA, et al. Drug Discov Today. 2007 Aug;12(15-16):622-33. doi: 10.1016/j.drudis.2007.06.008. Epub 2007 Aug 2. Drug Discov Today. 2007. PMID: 17706543 Review.
• Kinase-targeted libraries: the design and synthesis of novel, potent, and selective kinase inhibitors.

  Akritopoulou-Zanze I, Hajduk PJ. Akritopoulou-Zanze I, et al. Drug Discov Today. 2009 Mar;14(5-6):291-7. doi: 10.1016/j.drudis.2008.12.002. Epub 2009 Jan 21. Drug Discov Today. 2009. PMID: 19121409 Review.
• Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2.

  Prudent R, Moucadel V, Laudet B, Barette C, Lafanechère L, Hasenknopf B, Li J, Bareyt S, Lacôte E, Thorimbert S, Malacria M, Gouzerh P, Cochet C. Prudent R, et al. Chem Biol. 2008 Jul 21;15(7):683-92. doi: 10.1016/j.chembiol.2008.05.018. Chem Biol. 2008. PMID: 18635005